Previous 10 | Next 10 |
JERUSALEM and CLEVELAND, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Today, Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and MIM Software Inc. (“MIM Software”), a leading global provider of medica...
Gainers: Blue Water Vaccines ( BWV ) +57% . Eargo ( EAR ) +49% . Cassava Sciences ( SAVA ) +29% . MiNK Therapeutics ( INKT ) +24% . Cogent Biosciences ( COGT ) +16% . Losers: Blueprint Medicines ( BPMC ) -22% ....
2022 has been rough on stocks against the backdrop of rising global inflation, Russia’s invasion of Ukraine, spiking energy prices, mounting political tensions in the U.S., and more. Some of these reasons have been cited by blue chip companies for less-than-rosy guidance, which, unders...
JERUSALEM, July 05, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it will host a hybrid in-person/virtual key opinion leader...
Gainers: Rubicon Technology ( RBCN ) +68% . Faraday Future Intelligent Electric ( FFIE ) +65% . Ra Medical Systems ( RMED ) +61% . Xilio Therapeutics ( XLO ) +35% . Maris-Tech ( MTEK ) +35% . Lexicon Pharmaceuticals ( LXRX ...
Alpha Tau ( NASDAQ: DRTS ) stock jumped 31% on Tuesday after dropping 16% in the prior session. Shares of the Israeli medical device maker opened at $7.89. The stock recently changed hands at $9.91, up 31%, at approximately 12:05 p.m. ET. Alpha Tau shares rallied in mi...
Gainers: Alpha Tau Medical ( DRTS ) +42% . Precigen ( PGEN ) +20% . Amylyx Pharmaceuticals ( AMLX ) +18% . bluebird bio ( BLUE ) +13% . Talaris Therapeutics ( TALS ) +11% . Losers: Revelation Biosciences ( REVB ...
Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT™ PR Newswire JERUSALEM , June 22, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therap...
Shares of Israeli medical device maker Alpha Tau (DRTS) slid 11% on Friday after rallying 25% the previous day on news that it had received two licenses that would enable it to expand production. Alpha Tau shares opened at $11.75, recently changing hands at $11.09, down 11%, at approximately ...
Do You Have These 4 Biotech Stocks on Your Watchlist? Biotech stocks have been one of the focal points of the stock market over the past two years. For obvious reasons, people and investors alike are always on the lookout for new developments against the coronavirus. But even wi...
News, Short Squeeze, Breakout and More Instantly...
Alpha Tau Medical Ltd. Company Name:
DRTS Stock Symbol:
NASDAQ Market:
Alpha Tau Medical Ltd. Website:
The pooled analysis included data from 4 i nternational clinical trials spanning a n array of hard-to-treat indications including skin, head & neck, and oral cavity. Initial response data demonstrated an overall response rate of almost 100% in tre...
2024-05-21 10:00:22 ET Jason Bednar from Piper Sandler issued a price target of $7.00 for DRTS on 2024-05-21 08:51:00. The adjusted price target was set to $7.00. At the time of the announcement, DRTS was trading at $2.91. The overall price target consensus is at $12.00 ...
JERUSALEM, May 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that CFO Raphi Levy will present a corporate overview an...